Autologous circulating angiogenic cells treated with osteopontin and delivered via a collagen scaffold enhance wound healing in the alloxan-induced diabetic rabbit ear ulcer model

Stem Cell Research and Therapy

Volumn 4, Issue 6, 2013, Pages

  O'Loughlin, Aonghus ^a   Kulkarni, Mangesh ^a   Vaughan, Erin E ^a   Creane, Michael ^a   Liew, Aaron ^a   Dockery, Peter ^a   Pandit, Abhay ^a   O'Brien, Timothy ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; INSULIN GLARGINE; OSTEOPONTIN; TISSUE SCAFFOLD;

ALLOXAN-INDUCED DIABETES MELLITUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS CIRCULATING ANGIOGENIC CELL TRANSPLANTATION; CONTROLLED STUDY; DIABETES MELLITUS; EAR DISEASE; EAR ULCER; HYPERGLYCEMIA; IN VIVO STUDY; MALE; NEW ZEALAND WHITE (RABBIT); NONHUMAN; PRIORITY JOURNAL; SKIN ULCER; STEM CELL TRANSPLANTATION; THERAPY EFFECT; WOUND CLOSURE; WOUND HEALING;

ORYCTOLAGUS CUNICULUS;

ALLOXAN; ANIMALS; CELLS, CULTURED; COLLAGEN TYPE I; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; EAR DISEASES; ENDOTHELIAL CELLS; MALE; OSTEOPONTIN; RABBITS; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS; ULCER; WOUND HEALING;

EID: 84891358572     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt388     Document Type: Article

References (35)

1. Review paper: basic concepts to novel therapies: a review of the diabetic foot. O'Loughlin A, McIntosh C, Dinneen SF, O'Brien T, Int J Low Extrem Wounds 2010 9 90 102 10.1177/1534734610371600 20483808
2. Diabetic foot disorders. A clinical practice guideline (2006 revision). Frykberg RG, Zgonis T, Armstrong DG, Driver DG, Driver VR, Giurini JM, Kravitz SR, Landsman AS, Lavery LA, Moore JC, Schuberth JM, Wukich DK, Anderson C, Vanore JV, American College of Foot and Ankle Surgeons, J Foot Ankle Surg 2006 45 1 66 10.1053/j.jfas.2005.10.013 16399551 (Pubitemid 43052979)
3. Wound repair and regeneration. Gurtner GC, Werner S, Barrandon Y, Longaker MT, Nature 2008 453 314 321 10.1038/nature07039 18480812 (Pubitemid 351693137)
4. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Baum CL, Arpey CJ, Dermatol Surg 2005 31 674 686 15996419 (Pubitemid 43093424)
5. Cutaneous wound healing. Singer AJ, Clarke RA, N Engl J Med 1999 341 738 746 10.1056/NEJM199909023411006 10471461 (Pubitemid 29407375)
6. Cellular and molecular basis of wound healing in diabetes. Brem H, Tomic-Canic M, J Clin Invest 2007 117 1219 1222 10.1172/JCI32169 17476353 (Pubitemid 46718408)
7. Wound healing and its impairment in the diabetic foot. Falanga V, Lancet 2005 366 1736 1743 10.1016/S0140-6736(05)67700-8 16291068 (Pubitemid 41587454)
8. Chemokines, cytokines and growth factors in keratinocytes and dermal endothelial cell in the margin of chronic diabetic foot ulcers. Galkawska H, Wojewodzka U, Olszewski WL, Wound Repair Regen 2006 14 558 565 10.1111/j.1743-6109.2006.00155.x 17014667 (Pubitemid 44470072)
9. Decreased macrophage number and activitation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Maruyama K, Asai J, Li M, Thorne T, Losordo DW, D'Amore PA, Am J Pathol 2007 170 1178 1191 10.2353/ajpath.2007.060018 17392158 (Pubitemid 47339326)
10. Isolation of putative progenitor endothelial cells for angiogenesis. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM, Science 1997 275 964 967 10.1126/science.275.5302.964 9020076 (Pubitemid 27087709)
11. Assessing identity, phenotype, and fate of endothelial progenitor cells. Hirschi KK, Ingram DA, Yoder MC, Arterioscler Thromb Vasc Biol 2008 28 1584 1595 10.1161/ATVBAHA.107.155960 18669889
12. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearnet M, Li T, Isner JM, Asahara T, Proc Natl Acad Sci U S A 2000 97 3422 3427 10.1073/pnas.97.7.3422 10725398 (Pubitemid 30183318)
13. Working hypothesis to redefine endothelial progenitor cells. Prater DN, Case J, Ingram DA, Yoder MC, Leukemia 2007 21 1141 1149 10.1038/sj.leu.2404676 17392816 (Pubitemid 46831802)
14. Dibutyryl cAMP influences endothelial progenitor cell recruitment during wound neovascularization. Asai J, Takenaka H, Katoh N, Kishimoto S, J Invest Dermatol 2006 126 1159 1167 10.1038/sj.jid.5700188 16514413
15. Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice. Marrotte EJ, Chen DD, Hakim JS, Chen AF, J Clin Invest 2010 120 4207 4219 10.1172/JCI36858 21060152
16. Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Suh W, Kim KL, Kim JM, Shin IS, Lee YS, Lee JY, Jang HS, Lee JS, Byun J, Choi JH, Jeon ES, Kim DK, Stem Cells 2005 23 1571 1578 10.1634/stemcells.2004-0340 16081667 (Pubitemid 41741006)
17. Endothelial progenitor cells for the treatment of diabetic vasculopathy: panacea or Pandora's box? Liew A, McDermott JH, Barry F, O'Brien T, Diabetes Obes Metab 2008 10 353 366 10.1111/j.1463-1326.2007.00754.x 17825082 (Pubitemid 351524283)
18. Pre-treatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease. Vaughan EE, Liew A, Mashayekhi K, Dockery P, McDermott J, Kealy B, Flynn A, Duffy A, Coleman C, O'Regan A, Barry FB, O'Brien T, Cell Transplant 2012 21 1095 1107 10.3727/096368911X623880 22304991
19. Material-based deployment enhances efficacy of endothelial progenitor cells. Silva EA, Kim ES, Kong HJ, Mooney DJ, Proc Natl Acad Sci U S A 2008 105 14347 14352 10.1073/pnas.0803873105 18794520
20. Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing. Kim JY, Song SH, Kim KL, Ko JJ, Im JE, Yie SW, Ahn YK, Kim DK, Suh W, Cell Transplant 2010 19 1635 1644 10.3727/096368910X516637 20659357
21. Amine functionalization of collagen matrices with multifunctional polyethylene glycol systems. Ward J, Kelly J, Wang W, Zeugolis DI, Pandit A, Biomacromolecules 2010 11 3093 3101 10.1021/bm100898p
22. Type II collagen-hyaluronan hydrogel-a step towards a scaffold for intervertebral disc tissue engineering. Calderon L, Collin E, Velasco-Bayon D, Murphy M, O'Halloran D, Pandit A, Eur Cell Mater 2010 6 134 146
23. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S, Circ Res 2001 89 1 E7 10.1161/hh1301.093953 11440984
24. Stereological methods to assess tissue response for tissue-engineered scaffolds. Garcia Y, Breen A, Burugapalli K, Dockery P, Pandit A, Biomaterials 2007 28 175 186 10.1016/j.biomaterials.2006.08.037 16962656 (Pubitemid 44537386)
25. The quantification of vascular beds: a stereological approach. Dockery P, Fraher J, Exp Mol Pathol 2007 829 110 120 (Pubitemid 46483383)
26. Howard CV, Reed MG, Unbiased Stereology Belfast, UK: QTP Publications 2 2010
27. Unbiased estimation of curve length in 3D using vertical Sections. Gohkale AM, J Microsc 1990 159 133 141 10.1111/j.1365-2818.1990.tb04771.x
28. Assessment of wound healing in the alloxan-induced diabetic rabbit ear model. Breen A, McRedmond G, Dockery P, O'Brien T, Pandit A, J Invest Surg 2008 21 261 269 10.1080/08941930802216807 19160134
29. Stereologic methods and their application in kidney research. Nyengaard JR, J Am Soc Nephrol 1999 10 1100 1123 10232698 (Pubitemid 29203099)
30. Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1alpha mediated bone marrow mobilization impair diabetic tissue repair. Tepper OM, Carr J, Allen RJ, Chang CC, Lin CD, Tanaka R, Gupta SM, Levine JP, Saadeh PB, Warren SM, Diabetes 2010 59 1974 1983 10.2337/db09-0185 20484135
31. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N, Shrayer D, Carson P, Tissue Eng 2007 139 1299 1312 (Pubitemid 46986730)
32. Paracrine effects of adipose-derived stem cells on keratinocytes and dermal fibroblasts. Lee SH, Jin SY, Song JS, Seo KK, Cho KH, Ann Dermatol 2012 24 136 143 10.5021/ad.2012.24.2.136 22577262
33. Multiple applications of alamar blue as an indicator of metabolic function and cellular health in cell viability bioassays. Rampersad SN, Sensors 2012 12 12347 12360 10.3390/s120912347 23112716
34. A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability. Larson EM, Doughman DJ, Gregerson DS, Obritsch WF, Invest Opthalmol Vis Sci 1997 38 1929 1933 (Pubitemid 27407511)
35. Angiogenesis in collagen I requires alpha2beta1 ligation of a GFP*GER sequence and possibly p38 MAPK activation and focal adhesion disassembly. Sweeney SM, DiLullo G, Slater SJ, Martinez J, Iozzo RV, Lauer-Fields JL, Fields GB, San Antonio JD, J Biol Chem 2003 278 30516 30524 10.1074/jbc.M304237200 12788934 (Pubitemid 36994555)